Clasificación en acciones
#10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Precio por acción
$19.81
Última sincronización: 2026-08-28
Capitalización bursátil
$891.32M
Comercio Beta Bionics, Inc. (BBNX)
Precio BBNX con Capital del mercado a B
Capitalización de mercado de Beta Bionics, Inc.(BBNX)
Capitalización bursátil: $891.32M
A fecha de August 2026, Beta Bionics, Inc. tiene una capitalización de mercado de $891.32M. Esto convierte a Beta Bionics, Inc. en la 10096th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Beta Bionics, Inc. desde 2025 hasta 2026
BBNX en comparación con los más populares 5 títulos stocks
| Precio por BBNX |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.264T
|
+590,468.44%
|
|
|
|
|
$4.701T
|
+527,349.64%
|
|
|
|
|
$4.177T
|
+468,549.57%
|
|
|
|
|
$3.817T
|
+428,185.19%
|
|
|
|
|
$2.866T
|
+321,482.56%
|
